Celldex Therapeutics, Inc. 4
4 · Celldex Therapeutics, Inc. · Filed Jun 11, 2015
Insider Transaction Report
Form 4
Davis Thomas Andrew
Sr. VP & CMO
Transactions
- Award
Incentive Stock Option
2015-06-10+116,500→ 116,500 totalExercise: $25.41From: 2016-06-10Exp: 2025-06-10→ Common Stock (116,500 underlying)
Footnotes (1)
- [F1]25% vest on June 10, 2016 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.